Laurel Wealth Advisors (North Carolina)’s Arcutis Biotherapeutics ARQT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2021
Q4
Sell
-440
Closed -$11K 665
2021
Q3
$11K Hold
440
﹤0.01% 401
2021
Q2
$12K Buy
+440
New +$12K ﹤0.01% 437